Asthma and COVID-19: What do we know now

被引：19
|
作者：
Hughes-Visentin, Alexzandra [1 ]
Paul, Anthea B. Mahesan [2 ]
机构：
[1] Univ Ottawa, Fac Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
[2] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada
来源：
CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE | 2020年 / 14卷
关键词：
COVID-19; asthma; respiratory; biologics; treatment; corticosteroids; CORONAVIRUS DISEASE 2019; CLINICAL CHARACTERISTICS; PNEUMONIA; SARS-COV-2; NEBULIZER; WUHAN; RISK;
D O I：
10.1177/1179548420966242
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis. In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy. This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1).
引用
收藏
页数：7
相关论文
共 50 条
  • [21] COVID-19 in dental care: What do we know?
    Chmielewski, Marek
    Zalachowska, Oliwia
    Rybakowska, Weronika
    Komandera, Dominika
    Knura, Agata
    Albert, Adrian
    Kostanowicz, Julia
    Garbacz, Katarzyna
    JOURNAL OF ORAL MICROBIOLOGY, 2021, 13 (01)
  • [22] Vasculitis and COVID-19: what do we have to know?
    Tamburello, Antonio
    Castelno, Laura
    Bizzi, Emanuele
    Caso, Francesco
    ITALIAN JOURNAL OF MEDICINE, 2020, 14 (04) : 213 - 215
  • [23] Erythema Multiforme and COVID-19: What Do We Know?
    Bennardo, Luigi
    Nistico, Steven Paul
    Dastoli, Stefano
    Provenzano, Eugenio
    Napolitano, Maddalena
    Silvestri, Martina
    Passante, Maria
    Patruno, Cataldo
    MEDICINA-LITHUANIA, 2021, 57 (08):
  • [24] COVID-19 vaccines and pregnancy: What do we know?
    Cottin, Judith
    Benevent, Justine
    Khettar, Sophie
    Lacroix, Isabelle
    THERAPIE, 2021, 76 (04): : 373 - 374
  • [25] COVID-19, gender and estroprogestins, what do we know?
    Fidecicchi, Tiziana
    Fruzzetti, Franca
    Lete Lasa, Luis Ignacio
    Calaf, Joaquim
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2022, 27 (01): : 67 - 74
  • [26] Anesthesia and COVID-19: What We Should Know and What We Should Do
    Tang, Linda Y.
    Wang, Jingping
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2020, 24 (02) : 127 - 137
  • [27] COVID-19, asthma, and biological therapies: What we need to know
    Morais-Almeida, Mario
    Aguiar, Rita
    Martin, Bryan
    Ansotegui, Ignacio J.
    Ebisawa, Motohiro
    Arruda, L. Karla
    Caminati, Marco
    Canonica, Giorgio Walter
    Carr, Tara
    Chupp, Geoffrey
    Corren, Jonathan
    Davila, Ignacio
    Park, Hae-Sim
    Hanania, Nicola A.
    Rosenwasser, Lanny
    Sanchez-Borges, Mario
    Virchow, J. Christian
    Yanez, Anahi
    Bernstein, Jonathan A.
    Caraballo, Luis
    Chang, Yoon-Seok
    Chikhladze, Manana
    Fiocchi, Alessandro
    Gonzalez-Diaz, Sandra N.
    Tanno, Luciana Kase
    Levin, Michael
    Ortega-Martell, Jose Antonio
    Passalacqua, Giovanni
    Peden, David B.
    Rouadi, Philip W.
    Sublett, James L.
    Wong, Gary W. K.
    Bleecker, Eugene R.
    WORLD ALLERGY ORGANIZATION JOURNAL, 2020, 13 (05):
  • [28] Evidence-based physical activity for COVID-19: what do we know and what do we need to know?
    Gualano, Bruno
    BRITISH JOURNAL OF SPORTS MEDICINE, 2022, 56 (12) : 653 - 654
  • [29] Covid-19 and dizziness: what do we know so far?
    Mezzalira, Raquel
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2022, 88 (03) : 287 - 288
  • [30] Immune response in COVID-19: What do we currently know?
    Oliveira, Daniela S.
    Medeiros, Nayara I.
    Gomes, Juliana A. S.
    MICROBIAL PATHOGENESIS, 2020, 148
12345